Your browser doesn't support javascript.
loading
"Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
Magliozzi, Roberta; Fadda, Giulia; Brown, Robert A; Bar-Or, Amit; Howell, Owain W; Hametner, Simon; Marastoni, Damiano; Poli, Alberto; Nicholas, Richard; Calabrese, Massimiliano; Monaco, Salvatore; Reynolds, Richard.
Afiliación
  • Magliozzi R; Neurology Section of Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
  • Fadda G; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Brown RA; Center for Neuroinflammation and Experimental Therapeutics and the Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Bar-Or A; ShadowLab Research Inc., Toronto, Ontario, Canada.
  • Howell OW; Center for Neuroinflammation and Experimental Therapeutics and the Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Hametner S; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Marastoni D; Institute of Life Sciences, Swansea University, Swansea, UK.
  • Poli A; Brain Research Center, Medical University of Vienna, Vienna, Austria.
  • Nicholas R; Neurology Section of Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
  • Calabrese M; Neurology Section of Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
  • Monaco S; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Reynolds R; Neurology Section of Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
Ann Neurol ; 92(4): 670-685, 2022 10.
Article en En | MEDLINE | ID: mdl-35748636

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quitinasas / Esclerosis Múltiple Crónica Progresiva / Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Neurol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quitinasas / Esclerosis Múltiple Crónica Progresiva / Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Neurol Año: 2022 Tipo del documento: Article País de afiliación: Italia